MO
OGN icon

McMillan Office’s Organon & Co OGN Stock Holding History

McMillan Office’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.49K Sell
1,250
-247
-16% -$1.86K ﹤0.01% 406
2025
Q4 		$10.7K Buy
+1,497
New +$11.8K ﹤0.01% 380

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

McMillan Office's OGN Position: Q1 2026 in Review

McMillan Office reduced its Organon & Co (OGN) stake by 16% in Q1 2026, selling an estimated $1.86K and leaving 1,250 shares worth $7.49K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

McMillan Office first reported a position in OGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.7K in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • McMillan Office held 1,250 shares of Organon & Co worth $7.49K as of Q1 2026.
  • McMillan Office sold 247 Organon & Co shares in Q1 2026, an estimated $1.86K.
  • Organon & Co made up ﹤0.01% of McMillan Office's portfolio in Q1 2026, its #406 holding.
  • McMillan Office first reported a position in Organon & Co in Q4 2025 and has held it in 2 quarters since.
  • McMillan Office's Organon & Co position peaked at $10.7K in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on McMillan Office's 13F filing for Q1 2026, filed 23 Apr 2026.